Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Delcath Systems Inc DCTH

Healthcare Medical Devices Diagnostics & Research
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's products, HEPZATO KIT (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan (CHEMOSAT) percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while... see more

Recent & Breaking News (NDAQ:DCTH)

The Rosen Law Firm Reminds Delcath Investors of Important Class Action Deadline -- DCTH

Globe Newswire June 5, 2013

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Delcath Systems, Inc. of Class Action Lawsuit and Upcoming Deadline -- DCTH

Globe Newswire May 31, 2013

Lifshitz Law Firm Announces Investigation of Aruba Networks, Inc., Delcath Systems, Inc., and Digital Generation, Inc.

PR Newswire May 28, 2013

Record Use of At-the-Market (ATM) Offerings Continues in 2013 with $161 Million Raised by U.S. Life Sciences Companies in First Quarter, Reports Brinson Patrick

PR Newswire May 28, 2013

Law Offices of Todd M. Garber Announces Investigation of Delcath Systems, Inc.

Business Wire May 25, 2013

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 from Investment in Delcath Systems, Inc. to Contact Brower Piven Before the July 8, 2013 Lead Plaintiff Deadline

Business Wire May 20, 2013

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Delcath Systems, Inc.

Business Wire May 20, 2013

INVESTOR NOTICE: The Rosen Law Firm Announces Securities Fraud Class Action Against Delcath Systems, Inc. - DCTH

Business Wire May 20, 2013

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm

PR Newswire May 18, 2013

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Delcath Systems, Inc. of Class Action Lawsuit and Upcoming Deadline -- DCTH

Globe Newswire May 17, 2013

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Delcath Systems, Inc. to Contact Brower Piven Before the July 8, 2013 Lead Plaintiff Deadline -- DCTH

Globe Newswire May 10, 2013

Delcath Systems, Inc. Sued by Investor

PR Newswire May 10, 2013

Delcath Systems Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire May 10, 2013

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Delcath Systems, Inc. (NASDAQ: DCTH)

Marketwired May 10, 2013

Today's Research on DCTH, AKRX, ASTX, BMRN, and FRX

Accesswire May 10, 2013

Pomerantz Law Firm Has Filed a Class Action Against Delcath Systems, Inc. and Certain Officers -- DCTH

Globe Newswire May 8, 2013

DELCATH REPORTS 2013 FIRST QUARTER RESULTS

Thomson Reuters ONE May 8, 2013

Free Research Reports on CIM, DCTH, PKT and TDC Issued by the Bedford Report

Marketwired May 6, 2013

DELCATH PROVIDES UPDATE ON FDA ADVISORY COMMITTEE MEETING ON MELBLEZTM KIT

Thomson Reuters ONE May 2, 2013

TRADING OF DELCATH COMMON STOCK HALTED

Thomson Reuters ONE May 2, 2013